Literature DB >> 8995442

Endoprotease activities other than furin and PACE4 with a role in processing of HIV-I gp160 glycoproteins in CHO-K1 cells.

N M Inocencio1, J F Sucic, J M Moehring, M J Spence, T J Moehring.   

Abstract

We addressed the question of whether furin is the endoprotease primarily responsible for processing the human immunodeficiency virus type I (HIV-I) envelope protein gp160 in mammalian cells. The furin-deficient Chinese hamster ovary (CHO)-K1 strain RPE.40 processed gp160 as efficiently as wild-type CHO-K1 cells in vivo. Although furin can process gp160 in vitro, this processing is probably not physiologically relevent, because it occurs with very low efficiency. PACE4, a furin homologue, allowed processing of gp160 when both were expressed in RPE.40 cells. Further, PACE4 participated in the activation of a calcium-independent protease activity in RPE.40 cells, which efficiently processed the gp160 precursor in vitro. This calcium-independent protease activity was not found in another furin-deficient cell strain, 7.P15, selected from the monkey kidney cell line COS-7.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995442     DOI: 10.1074/jbc.272.2.1344

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits.

Authors:  R W Sanders; L Schiffner; A Master; F Kajumo; Y Guo; T Dragic; J P Moore; J M Binley
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  Assembly of urothelial plaques: tetraspanin function in membrane protein trafficking.

Authors:  Chih-Chi Andrew Hu; Feng-Xia Liang; Ge Zhou; Liyu Tu; Chih-Hang Anthony Tang; Jessica Zhou; Gert Kreibich; Tung-Tien Sun
Journal:  Mol Biol Cell       Date:  2005-06-15       Impact factor: 4.138

3.  Human Ubc9 contributes to production of fully infectious human immunodeficiency virus type 1 virions.

Authors:  Tareq Jaber; Christopher R Bohl; Gentry L Lewis; Charles Wood; John T West; Robert A Weldon
Journal:  J Virol       Date:  2009-07-29       Impact factor: 5.103

4.  Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.

Authors:  R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

5.  Wild-type-like viral replication potential of human immunodeficiency virus type 1 envelope mutants lacking palmitoylation signals.

Authors:  Woan-Eng Chan; Hui-Hua Lin; Steve S-L Chen
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Modulation of prohormone convertase 1/3 properties using site-directed mutagenesis.

Authors:  Akihiko Ozawa; Juan R Peinado; Iris Lindberg
Journal:  Endocrinology       Date:  2010-07-07       Impact factor: 4.736

7.  Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases.

Authors:  I Yana; S J Weiss
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

8.  Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.

Authors:  James M Binley; Rogier W Sanders; Aditi Master; Charmagne S Cayanan; Cheryl L Wiley; Linnea Schiffner; Bruce Travis; Shawn Kuhmann; Dennis R Burton; Shiu-Lok Hu; William C Olson; John P Moore
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

9.  Furin processing and proteolytic activation of Semliki Forest virus.

Authors:  Xinyong Zhang; Martin Fugère; Robert Day; Margaret Kielian
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

10.  A study of human furin specificity using synthetic peptides derived from natural substrates, and effects of potassium ions.

Authors:  Mario A Izidoro; Iuri E Gouvea; Jorge A N Santos; Diego M Assis; Vitor Oliveira; Wagner A S Judice; Maria A Juliano; Iris Lindberg; Luiz Juliano
Journal:  Arch Biochem Biophys       Date:  2009-05-27       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.